Skip to main content
Equibles

Alan A. Musso

Fulcrum Therapeutics, Inc. (FULC)

CFO

Fulcrum Therapeutics, Inc. (FULC)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Alan A. Musso

Alan A. Musso is recorded as CFO at Fulcrum Therapeutics, Inc. (FULC). Fulcrum Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that Alan A. Musso was appointed principal financial officer, effective August 7, 2023. Fulcrum Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that Alan A. Musso was appointed chief financial officer and treasurer, effective August 7, 2023.

“Mr. Musso will also succeed Mr. Sapir, Fulcrum's president and chief executive officer, as principal financial officer, effective August 7, 2023.”
Fulcrum Therapeutics, Inc. Form 8-K, filed August 3, 2023 · Read the filing
“On August 2, 2023, Fulcrum's board of directors, or the Board, appointed Alan A. Musso as Fulcrum's chief financial officer and treasurer, effective August 7, 2023.”
Fulcrum Therapeutics, Inc. Form 8-K, filed August 3, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Fulcrum Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.